[Cytologic classification in the diagnosis and prognostic evaluation of plasmocytoma]

[New beta0-thalassaemic insertion mutation (CD 7/8, +G) in a Slovak family, associated with the Mediterranean haplotype IX].

Vnitrni lekarstvi·2005

[Bone changes in multiple myeloma--current etiopathogenic, diagnostic and therapeutic aspects].

Vnitrni lekarstvi·2002

[Richter's syndrome (bimorphologic malignant lymphoma)].

Vnitrni lekarstvi·2002

Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma.

Cancer chemotherapy and pharmacology·2001

[Induction of autoimmune phenomena in lymphoproliferative diseases].

Bratislavske lekarske listy·2001

[Autologous stem cell transplantation in a patient with juvenile chronic arthritis].

Vnitrni lekarstvi·2000

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023

Pre-operative circulating tumour DNA in high-risk primary cutaneous melanoma: prospective feasibility in molecular pathology.

Acta oncologica (Stockholm, Sweden)·2026

Prognostic Associations of BMI and Metabolic Syndrome With Outcomes After Anti-PD-1 Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Immunology·2026

Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.

Journal of the National Cancer Institute·2026

Real-world treatment landscape and clinical outcomes in first-line advanced or metastatic gastroesophageal adenocarcinoma in the United States.

The oncologist·2026

Integrative multi-omics profiling of insomnia-related molecular features reveals microbiome, immune, and therapy-relevant heterogeneity in colorectal cancer.

Microbiology spectrum·2026

Predicting pancreatic cancer in high-risk individuals and in the general population: how long is the road yet?

Revista espanola de enfermedades digestivas·2026

Related Experiment Videos

[Cytologic classification in the diagnosis and prognostic evaluation of plasmocytoma]

Related Concept Videos

[New beta0-thalassaemic insertion mutation (CD 7/8, +G) in a Slovak family, associated with the Mediterranean haplotype IX].

[Bone changes in multiple myeloma--current etiopathogenic, diagnostic and therapeutic aspects].

[Richter's syndrome (bimorphologic malignant lymphoma)].

Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma.

[Induction of autoimmune phenomena in lymphoproliferative diseases].

[Autologous stem cell transplantation in a patient with juvenile chronic arthritis].

Pharmacological profile of mepolizumab.

Atypical form of Goodpasture's disease.

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Dyslipidemia - the known unknown.

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Implications of highly suppressive treatment HIV infection.

Pre-operative circulating tumour DNA in high-risk primary cutaneous melanoma: prospective feasibility in molecular pathology.

Prognostic Associations of BMI and Metabolic Syndrome With Outcomes After Anti-PD-1 Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.

Real-world treatment landscape and clinical outcomes in first-line advanced or metastatic gastroesophageal adenocarcinoma in the United States.

Integrative multi-omics profiling of insomnia-related molecular features reveals microbiome, immune, and therapy-relevant heterogeneity in colorectal cancer.

Predicting pancreatic cancer in high-risk individuals and in the general population: how long is the road yet?

Related Experiment Videos

[Cytologic classification in the diagnosis and prognostic evaluation of plasmocytoma]

Related Concept Videos

Related Articles